AstraSana Japan Co., Ltd. Enters Capital and Business Alliance with GSI Creos Corporation to Enhance CBD Raw Material Distribution Across Japan
Kloten / Tokyo – AstraSana Japan Co., Ltd., a subsidiary of the AstraSana Group headquartered in Switzerland, has announced a strategic partnership with Japan’s GSI Creos Corporation. This alliance, backed by a significant investment, aims to strengthen the wholesale distribution of CBD raw materials in the Japanese market by leveraging the strengths of both companies.
Through this collaboration, AstraSana Group will establish a robust supply chain to deliver high-quality, Swiss-made CBD raw materials nationwide in Japan. The company’s mission is to ensure customers receive safe and reliable products of the highest standard.
“The partnership with GSI Creos will enable us to provide even higher-quality services to our customers,” said a spokesperson for AstraSana. “By leveraging their extensive resources and networks, we will actively contribute to the growth and development of the CBD market in Japan.”
AstraSana is committed to prioritizing safety through third-party analyses, delivering superior-quality products, and placing customer trust and satisfaction at the heart of its operations. The company aims to enhance customers’ “Quality of Life” (QOL) while remaining at the forefront of technological innovation.
The potential of CBD in the Japanese market is immense, with global demand on the rise. As a hemp-derived compound legally recognized as a safe material in Japan, CBD offers significant opportunities for growth and expansion. This collaboration will further strengthen AstraSana’s supply chain and promote the availability of safe and reliable CBD products throughout the country.
GSI Creos Corporation, with nine domestic and 24 international bases, is an innovative trading company operating globally in both “textiles” and “industrial products.” The company’s diverse range of businesses includes textile raw materials, apparel, chemicals, hobby materials, machinery, semiconductor components, and nanotechnology. Guided by the purpose of “Creating quality of life for the next generation,” GSI Creos is committed to ESG management to address social challenges and promote human well-being.
AstraSana Group, through its subsidiary AstraSana Holding AG, is a leading global company specializing in cannabinoid raw materials and medical cannabis. With headquarters in Zurich, Switzerland, the company operates through affiliates in the Czech Republic, the UK, and Japan. AstraSana Group also collaborates with partners across Europe and South America to expand its worldwide presence.
For further information, please contact:
Yves Antoniazzi
info@astrasana.com
Distributed by https://pressat.co.uk/
